Welcome to Inland Northwest Research

We are leaders in national and global research, focused on neurological disorders.  We offer high impact clinical trial opportunities in Parkinson’s Disease, Huntington’s Disease, Multiple Sclerosis, Alzheimer’s Disease and other forms of dementia, and ALS. We take great pride in helping those with neurological disorders navigate through clinical trial options, to explore options that are the best fit for their needs.

 

Our Mission

We strive to offer high quality clinical trials to those living with neurological disorders, in our region and beyond.

Inland Northwest Research (INWR) is located in Spokane, Washington. We started in 2018, with the goal of advancing medicine and personalizing medical care, again. We exist because of our research participants give their time and energy to our trial. In return, we conduct clinical trials with the highest ethical standards, kindness, and quality, while bringing innovative and cutting-edge research to the Inland Northwest. INWR offers innovative and diverse research for those suffering from neurological conditions.  

Our team is comprised of two dedicated and fellow trained Neurologists, Drs. Jason Aldred and Steven Pugh. Dr. Aldred is a movement disorders specialist with over 14 years of clinical research experience. Dr. Pugh is one of only a handful of MS physicians in the region. He has been conducting clinical research for over 15 years. We also have a dedicated staff of, Project Managers, Research Coordinators, Nurses, and admin staff, to ensure subjects are cared for and trials are run with attention.

You are the reason we exist! INWR is committed to the highest standards of research. We actively work with our subjects to provide the best possible care, to find better treatment, and hopefully a cure for diseases. Quality of life for our patients is our number one priority, and it is our hope that every patient feels compassion as they enter and leave our facility.


What is Clinical Research?

Clinical Research VS. Medical Treatment

In The News...